×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OSTX – os therapies incorporated (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OSTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:04 pm
ostx
Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) 3Q25 [Yahoo! Finance]
Low
Report
Stonegate Capital Partners Updates Coverage on OS Therapies Inc. (OSTX) 3Q25 [Yahoo! Finance]
11/20
08:16 am
ostx
OS Therapies to spin off OS Animal Health into a standalone public company [Seeking Alpha]
Medium
Report
OS Therapies to spin off OS Animal Health into a standalone public company [Seeking Alpha]
11/20
08:00 am
ostx
OS Therapies to Spinoff OS Animal Health into Standalone Public Company [Yahoo! Finance]
Medium
Report
OS Therapies to Spinoff OS Animal Health into Standalone Public Company [Yahoo! Finance]
11/17
06:36 am
ostx
OS Therapies GAAP EPS of -$0.21 misses by $0.08 [Seeking Alpha]
Low
Report
OS Therapies GAAP EPS of -$0.21 misses by $0.08 [Seeking Alpha]
10/10
06:07 am
ostx
OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma [Yahoo! Finance]
Medium
Report
OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma [Yahoo! Finance]
10/7
12:07 pm
ostx
OS Therapies to Participate in Fall 2025 Conferences and Events [Yahoo! Finance]
Neutral
Report
OS Therapies to Participate in Fall 2025 Conferences and Events [Yahoo! Finance]
9/30
08:04 pm
ostx
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update [Yahoo! Finance]
Low
Report
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update [Yahoo! Finance]
9/30
09:03 am
ostx
OS Therapies (NYSE:OSTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
Low
Report
OS Therapies (NYSE:OSTX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
Date
Time
Symbol
Headline
Impact
11/14
04:12 pm
ostx
Form 10-Q OS Therapies Inc For: Sep 30
Medium
Report
Form 10-Q OS Therapies Inc For: Sep 30
10/21
04:16 pm
ostx
Form 8-K OS Therapies Inc For: Oct 21
Low
Report
Form 8-K OS Therapies Inc For: Oct 21
10/17
05:07 pm
ostx
Form 8-K OS Therapies Inc For: Oct 14
Low
Report
Form 8-K OS Therapies Inc For: Oct 14
9/30
04:07 pm
ostx
Form 8-K OS Therapies Inc For: Sep 30
Medium
Report
Form 8-K OS Therapies Inc For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: